Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Submitted by
admin
on March 27, 2018 - 9:56pm
Source:
Fierce Pharma
News Tags:
Bristol-Myers Squibb
Opdivo
Yervoy
FDA
colorectal cancer
Headline:
Bristol-Myers' Opdivo-Yervoy combo scores again at FDA, this time in colorectal cancer
Do Not Allow Advertisers to Use My Personal information
